Neuromuscular blocking drugs in the critically ill

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 6, Issue 3, 2006, Pages 119-123

  Tripathi, S S ^a   Hunter, J M ^a  

^a Department of Anaesthesia ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646859417     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mkl017     Document Type: Article

References (12)

1. Elliot JM, Bion JF. The use of neuromuscular blocking drugs in intensive care practice. Acta Anaesthesiol Scand 1995; 39 (S106): 70-82
2. Murphy GS, Vender JS. Neuromuscular-blocking drugs: Use and misuse in the intensive care unit. Crit Care Clin 2001; 17: 925-42
3. Hunter JM. Neuromuscular blocking agents in intensive therapy. In: Pollard BJ, ed. Applied Neuromuscular Pharmacology. New York: Oxford University Press, 1994; 188-201
4. Sharpe MD. The use of muscle relaxants in the intensive care unit. Can J Anaesth 1992; 39: 949-62
5. Olivieri L, Plourde G. Prolonged (more than ten hours) neuromuscular blockade after cardiac surgery: Report of two cases. Can J Anesth 2005; 52: 88-93
6. Segredo V, Matthay MA, Sharma ML, Gruenke LD, Caldwell JE, Miller RD. Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. Anesthesiology 1990; 72: 566-70
7. Adejumo SWA, Hunter JM. Muscle relaxants in the critically ill. Curr Opin Crit Care 1999; 5: 263-8
8. Boyd AH, Eastwood NB, Parker CJR, Hunter JM. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Br J Anaesth 1996; 76: 382-8
9. Yate PM, Flynn PJ, Arnold RW, Weatherly BC, Simmonds RJ, Dopson T. Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit. Br J Anaesth 1987; 59: 211-17
10. Lefrant JY, Farenc C, Coussaye JEDL, et al. Pharmacodynamics and atracurium and laudanosine concentrations during a fixed continuous infusion of atracurium in mechanically ventilated patients with acute respiratory distress syndrome. Anaesth Intensive Care 2002; 30: 422-7
11. Klessig HT, Geiger HJ, Murray MJ, Coursin DB. A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants. Crit Care Med 1992; 20: 1341-5
12. Murray MJ, Strickland RA, Weiler C. The use of neuromuscular blocking drugs in the intensive care unit: A US perspective. Intensive Care Med 1993; 19: S40-4